Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT05586334

Development and Clinical Evaluation of an Innovative Medical Device to Predict Preterm Birth (PrediMAP)

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-11-20

3600

Participants Needed

1

Research Sites

233 weeks

Total Duration

On this page

Sponsors

A

Assistance Publique - Hôpitaux de Paris

Lead Sponsor

U

URC-CIC Paris Descartes Necker Cochin

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to clinically validate the predictive performance (sensitivity and specificity) of the PrediMAP in-vitro diagnostic medical device to predict delivery within 7 days in the target population of women consulting obstetric emergencies for preterm labor (PTL).

CONDITIONS

Official Title

Development and Clinical Evaluation of an Innovative Medical Device to Predict Preterm Birth (PrediMAP)

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant with live fetus(es)
  • Emergency room visit between 22 and 34 weeks + 6 days of pregnancy
  • Suspected preterm labor defined by uterine contractions during consultation and/or clinical or ultrasound changes of the cervix
  • Or visiting for another reason with clinical or ultrasound changes of the cervix
  • Have social security coverage or AME
  • Signed informed consent form
Not Eligible

You will not qualify if you...

  • Younger than 18 years
  • Premature rupture of membranes
  • In labor with imminent delivery
  • No social care coverage
  • Minor or legally protected adult (guardianship or curatorship)
  • Do not speak French and not accompanied by a French-speaking person
  • Multiple pregnancy with three or more fetuses

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Louis Mourier Hospital

Colombes, France, 92700

Actively Recruiting

Loading map...

Research Team

J

Jeanne SIBIUDE, MD, PhD

CONTACT

K

Karima MESBAHI IHADJADENE, Project Manager

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here